This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Personalized prediction of chemotherapy efficacy in osteosarcoma through patient-derived organoids: correlation with survival and tumor proliferation potential
Journal of Experimental & Clinical Cancer Research Open Access 11 December 2025
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Tiriac, H. et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 8, 1112–1129 (2018)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Maeng, J.E., Ku, JL. In-depth organoid profiling of pancreatic cancer. Nat Rev Cancer 24, 596 (2024). https://doi.org/10.1038/s41568-024-00726-2
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41568-024-00726-2
This article is cited by
-
Personalized prediction of chemotherapy efficacy in osteosarcoma through patient-derived organoids: correlation with survival and tumor proliferation potential
Journal of Experimental & Clinical Cancer Research (2025)